Advancing cell-based cancer immunotherapy through stem cell engineering.

CRISPR-Cas9 T cell T cell receptor allogeneic off-the-shelf cell therapy allorejection cancer immunotherapy chimeric antigen receptor embryonic stem cell feeder-free culture gamma delta T cell gene engineering graft-versus-host disease hematopoietic stem cell immune cell induced pluripotent stem cell invariant natural killer T cell lentivector mucosal-associated invariant T cell natural killer cell stem cell

Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
04 05 2023
Historique:
received: 17 05 2022
revised: 04 01 2023
accepted: 22 02 2023
pmc-release: 04 05 2024
medline: 8 5 2023
pubmed: 23 3 2023
entrez: 22 3 2023
Statut: ppublish

Résumé

Advances in cell-based therapy, particularly CAR-T cell therapy, have transformed the treatment of hematological malignancies. Although an important step forward for the field, autologous CAR-T therapies are hindered by high costs, manufacturing challenges, and limited efficacy against solid tumors. With ongoing progress in gene editing and culture techniques, engineered stem cells and their application in cell therapy are poised to address some of these challenges. Here, we review stem cell-based immunotherapy approaches, stem cell sources, gene engineering and manufacturing strategies, therapeutic platforms, and clinical trials, as well as challenges and future directions for the field.

Identifiants

pubmed: 36948187
pii: S1934-5909(23)00070-X
doi: 10.1016/j.stem.2023.02.009
pmc: PMC10164150
mid: NIHMS1879730
pii:
doi:

Substances chimiques

Receptors, Chimeric Antigen 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

592-610

Subventions

Organisme : NCI NIH HHS
ID : DP2 CA196335
Pays : United States

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests Y.-R.L., Z.S.D., P.W., and L.Y. are inventors on patents relating to this manuscript. Y.Y. is currently an employee of the Fate Therapeutics. P.W. is a co-founder, stockholder, consultant, and advisory board member of HRain Biotechnology, TCRCure Biopharma, and Appia Bio. L.Y. is a scientific advisor to AlzChem and Amberstone Biosciences and a co-founder, stockholder, and advisory board member of Appia Bio. None of the declared companies contributed to or directed any of the writing of this manuscript.

Références

Lancet. 2020 Dec 12;396(10266):1885-1894
pubmed: 33308471
Nat Med. 2018 Oct;24(10):1499-1503
pubmed: 30275568
Front Immunol. 2020 Nov 30;11:582939
pubmed: 33329555
Stem Cells Dev. 2011 Nov;20(11):1901-10
pubmed: 21231869
Nat Med. 2020 Dec;26(12):1878-1887
pubmed: 33020644
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1523-8
pubmed: 25605948
Nature. 2007 Jul 19;448(7151):313-7
pubmed: 17554338
Gene. 2017 Dec 15;636:36-41
pubmed: 28888577
Front Oncol. 2019 Mar 12;9:146
pubmed: 30915277
Nat Med. 2020 Nov;26(11):1686-1690
pubmed: 33046868
Br J Haematol. 2017 May;177(3):457-466
pubmed: 28295190
Nat Commun. 2019 Nov 19;10(1):5222
pubmed: 31745080
Nat Biotechnol. 2005 Mar;23(3):349-54
pubmed: 15723046
Tissue Antigens. 2015 Jun;85(6):443-9
pubmed: 25864470
Front Immunol. 2018 Feb 15;9:283
pubmed: 29497427
Stem Cells Int. 2012;2012:875059
pubmed: 22315618
Exp Mol Med. 2019 Jan 7;51(1):1-11
pubmed: 30617277
Cancer Res. 2016 Nov 15;76(22):6445-6451
pubmed: 27784742
Arch Pharm Res. 2019 Jul;42(7):543-548
pubmed: 30859410
Cell Stem Cell. 2018 Dec 6;23(6):850-858.e4
pubmed: 30449714
Sci Transl Med. 2014 Feb 19;6(224):224ra25
pubmed: 24553386
Front Immunol. 2018 Aug 13;9:1869
pubmed: 30150991
Nat Rev Drug Discov. 2020 Mar;19(3):185-199
pubmed: 31900462
Nat Med. 2021 Oct;27(10):1797-1805
pubmed: 34642489
Cancer Cell. 2019 Mar 18;35(3):489-503.e8
pubmed: 30889382
Front Immunol. 2019 Nov 12;10:2664
pubmed: 31798590
Hematol Oncol Clin North Am. 2017 Oct;31(5):897-912
pubmed: 28895855
Stem Cells. 2007 Oct;25(10):2601-9
pubmed: 17628020
Cancers (Basel). 2022 Jun 01;14(11):
pubmed: 35681730
Blood. 2012 May 24;119(21):5030-6
pubmed: 22371885
J Clin Invest. 2022 Jun 15;132(12):
pubmed: 35503659
Blood. 1997 Aug 1;90(3):1109-14
pubmed: 9242542
Cell. 2021 Dec 9;184(25):6081-6100.e26
pubmed: 34861191
Stem Cell Reports. 2022 May 10;17(5):1033-1047
pubmed: 35487213
Lancet. 2020 Sep 19;396(10254):839-852
pubmed: 32888407
Cancer Discov. 2018 Oct;8(10):1219-1226
pubmed: 30135176
J Clin Oncol. 2011 Mar 1;29(7):917-24
pubmed: 21282551
Clin Immunol. 2011 Aug;140(2):119-29
pubmed: 21095162
Trends Cancer. 2021 Dec;7(12):1059-1073
pubmed: 34479851
Biochem Soc Trans. 2016 Apr 15;44(2):412-8
pubmed: 27068948
Front Immunol. 2020 Oct 15;11:561553
pubmed: 33178188
Annu Rev Immunol. 2021 Apr 26;39:19-49
pubmed: 33428454
Stem Cell Reports. 2015 Oct 13;5(4):597-608
pubmed: 26321144
Nat Rev Immunol. 2019 Dec;19(12):723-733
pubmed: 31417198
Annu Rev Med. 2016;67:165-83
pubmed: 26332003
Stem Cells. 2020 Jan;38(1):67-79
pubmed: 31621975
Cells. 2021 Dec 10;10(12):
pubmed: 34944002
Blood. 2017 Dec 14;130(24):2594-2602
pubmed: 28928126
Nat Commun. 2021 Jan 18;12(1):430
pubmed: 33462228
Science. 2009 May 8;324(5928):797-801
pubmed: 19325077
Signal Transduct Target Ther. 2021 Feb 8;6(1):53
pubmed: 33558455
Cell Stem Cell. 2022 Aug 4;29(8):1181-1196.e6
pubmed: 35931029
Nature. 2001 May 17;411(6835):385-9
pubmed: 11357147
Blood. 2007 Jul 1;110(1):433-40
pubmed: 17371948
Nat Protoc. 2008;3(5):768-76
pubmed: 18451785
Cell. 2016 Oct 6;167(2):419-432.e16
pubmed: 27693353
J Leukoc Biol. 2014 Dec;96(6):1165-75
pubmed: 25157026
Nat Med. 2015 Aug;21(8):914-921
pubmed: 26193344
J Immunol. 2018 Jan 15;200(2):459-468
pubmed: 29311388
Front Immunol. 2013 Dec 02;4:409
pubmed: 24348476
Blood. 2011 Nov 3;118(18):4817-28
pubmed: 21849486
Cell. 2018 Dec 13;175(7):1958-1971.e15
pubmed: 30449619
Blood Adv. 2020 Nov 24;4(22):5868-5876
pubmed: 33232480
Stem Cell Res Ther. 2021 Jan 25;12(1):81
pubmed: 33494834
Sci Transl Med. 2013 Mar 20;5(177):177ra38
pubmed: 23515080
Nat Rev Immunol. 2012 Mar 22;12(4):239-52
pubmed: 22437937
Nat Med. 2022 Jun;28(6):1189-1198
pubmed: 35534566
Cancer Discov. 2021 May;11(5):1192-1211
pubmed: 33328215
Nat Rev Immunol. 2021 Dec;21(12):769-784
pubmed: 33879873
Methods Mol Biol. 2021;2388:35-57
pubmed: 34524660
Sci Transl Med. 2017 Jan 25;9(374):
pubmed: 28123068
Cell Rep. 2012 Dec 27;2(6):1722-35
pubmed: 23219550
Exp Hematol Oncol. 2022 Jun 20;11(1):38
pubmed: 35725570
Mol Ther Methods Clin Dev. 2021 Mar 05;21:171-179
pubmed: 33816647
Trends Pharmacol Sci. 2021 Jan;42(1):45-59
pubmed: 33250273
Nat Commun. 2022 Mar 25;13(1):1606
pubmed: 35338135
PLoS One. 2019 May 9;14(5):e0216815
pubmed: 31071196
Cell Stem Cell. 2013 Jan 3;12(1):114-26
pubmed: 23290140
Stem Cells. 2016 Jan;34(1):93-101
pubmed: 26503833
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10716-21
pubmed: 11535826
Nature. 2017 Mar 2;543(7643):113-117
pubmed: 28225754
Methods Mol Biol. 2019;1899:25-40
pubmed: 30649763
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5199-204
pubmed: 9560253
Mol Ther. 2023 Mar 1;31(3):631-646
pubmed: 36463401
Front Immunol. 2018 Jan 08;8:1935
pubmed: 29358940
Cell Stem Cell. 2012 Jun 14;10(6):678-684
pubmed: 22704507
Blood. 2016 Jul 28;128(4):519-28
pubmed: 27226436
Nat Methods. 2018 Sep;15(9):732-740
pubmed: 30127506
Front Immunol. 2017 Dec 22;8:1850
pubmed: 29312333
Circ Res. 2015 Jan 2;116(1):12-5
pubmed: 25552688
Front Med. 2017 Dec;11(4):554-562
pubmed: 28625015
J Hematol Oncol. 2020 Nov 11;13(1):153
pubmed: 33176869
J Clin Invest. 2007 Jun;117(6):1466-76
pubmed: 17549249
Cell Stem Cell. 2016 Oct 6;19(4):502-515
pubmed: 27424783
Stem Cells Transl Med. 2013 Jul;2(7):483-7
pubmed: 23757505
Cancers (Basel). 2021 Jan 16;13(2):
pubmed: 33467027
Bone Marrow Transplant. 2008 Jan;41(1):1-9
pubmed: 17982505
J Clin Invest. 2016 Jun 1;126(6):2123-38
pubmed: 27111235
Nat Methods. 2017 May;14(5):521-530
pubmed: 28369043
Cell Stem Cell. 2022 Apr 7;29(4):515-527.e8
pubmed: 35278370
Cell Stem Cell. 2015 Apr 2;16(4):357-66
pubmed: 25842976
Oncotarget. 2017 Jun 6;8(23):38022-38043
pubmed: 28410237
N Engl J Med. 2020 Feb 6;382(6):545-553
pubmed: 32023374
Nat Rev Genet. 2021 Jul;22(7):427-447
pubmed: 33603158
Nature. 2022 Apr;604(7906):563-570
pubmed: 35418687
Nat Biotechnol. 2009 Jul;27(7):606-13
pubmed: 19587662
Comp Cytogenet. 2013 Mar 14;7(1):1-9
pubmed: 24260685
Mol Ther. 2019 Jun 5;27(6):1126-1138
pubmed: 31005597
Antibodies (Basel). 2022 Apr 27;11(2):
pubmed: 35645204
Front Immunol. 2020 Nov 12;11:575609
pubmed: 33304346
Stem Cell Reports. 2016 Feb 9;6(2):213-27
pubmed: 26862702
J Immunol. 2005 Oct 15;175(8):5095-103
pubmed: 16210613
Cancer Sci. 2020 May;111(5):1478-1490
pubmed: 32133731
Cell. 2014 Sep 11;158(6):1254-1269
pubmed: 25215486
Front Med (Lausanne). 2022 May 09;9:897750
pubmed: 35615083
Blood. 2005 Jan 15;105(2):617-26
pubmed: 15374881
J Immunol. 2005 Nov 1;175(9):5799-808
pubmed: 16237072
Clin Pharmacol Ther. 2020 Jan;107(1):112-122
pubmed: 31622496
Sci Transl Med. 2021 Apr 28;13(591):
pubmed: 33910979
Nat Methods. 2017 May;14(5):531-538
pubmed: 28394335
Nat Commun. 2018 Dec 21;9(1):5416
pubmed: 30575746
Immunol Cell Biol. 2019 Aug;97(7):664-674
pubmed: 31009109
Mol Ther. 2017 Apr 5;25(4):949-961
pubmed: 28237835
Immunity. 2004 Aug;21(2):137-48
pubmed: 15308095
Cell. 2020 Apr 2;181(1):46-62
pubmed: 32243795
Nature. 2018 Jun;558(7709):307-312
pubmed: 29849141
Cell. 2017 Feb 9;168(4):724-740
pubmed: 28187291
J Immunother Cancer. 2021 Dec;9(12):
pubmed: 34916256
Semin Immunol. 2011 Aug;23(4):224-34
pubmed: 21958960
Cell Stem Cell. 2019 Oct 3;25(4):542-557.e9
pubmed: 31495780
Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-8
pubmed: 32347759
Hematol Oncol Stem Cell Ther. 2022 Dec 23;15(4):168-175
pubmed: 34699774
Lancet. 2005 Dec 10;366(9502):2019-25
pubmed: 16338451
Annu Rev Med. 2017 Jan 14;68:139-152
pubmed: 27860544
Cell Stem Cell. 2013 Jan 3;12(1):31-6
pubmed: 23290135
Semin Immunol. 2017 Jun;31:37-54
pubmed: 28838796
Cell Stem Cell. 2016 Sep 1;19(3):341-54
pubmed: 27476965
Science. 2009 May 8;324(5928):727-8
pubmed: 19423804
J Clin Invest. 2012 Jun;122(6):2221-33
pubmed: 22565311
Muscles Ligaments Tendons J. 2012 Oct 16;2(3):243-7
pubmed: 23738304
Am J Transplant. 2017 Apr;17(4):856-879
pubmed: 28117944
Nat Immunol. 2021 Aug;22(8):983-995
pubmed: 34282330
Nat Commun. 2020 May 8;11(1):2283
pubmed: 32385241
J Assist Reprod Genet. 2010 Jun;27(6):285-91
pubmed: 20393797
Cell Stem Cell. 2020 Oct 1;27(4):523-531
pubmed: 33007237
Nat Biomed Eng. 2021 May;5(5):429-440
pubmed: 34002062
Cell Stem Cell. 2013 May 2;12(5):546-58
pubmed: 23523177
Cancer Res. 2018 Aug 15;78(16):4692-4703
pubmed: 29967261
PLoS One. 2015 Mar 27;10(3):e0121788
pubmed: 25816339
Nat Protoc. 2017 Apr;12(4):828-863
pubmed: 28333914
Front Immunol. 2019 May 31;10:1205
pubmed: 31214177
Nat Biotechnol. 2019 Mar;37(3):252-258
pubmed: 30778232
Biol Blood Marrow Transplant. 2003 Jun;9(6):355-63
pubmed: 12813443
iScience. 2022 Aug 06;25(9):104859
pubmed: 36034226
Blood. 2005 Jul 1;106(1):376-83
pubmed: 15755898
Clin Cancer Res. 2019 Dec 1;25(23):7126-7138
pubmed: 31484667
J Virol. 2000 Jul;74(14):6564-9
pubmed: 10864670
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6204-9
pubmed: 11983911
Leukemia. 2018 Feb;32(2):520-531
pubmed: 28725044
Methods Mol Biol. 2022;2454:607-624
pubmed: 33945142
Cell Cycle. 2013 Aug 1;12(15):2341-2
pubmed: 23856578
Oncoimmunology. 2015 Apr 1;4(7):e1017701
pubmed: 26140247
Annu Rev Immunol. 2015;33:445-74
pubmed: 25622193
Life (Basel). 2022 Feb 16;12(2):
pubmed: 35207580
Nat Med. 2018 May;24(5):563-571
pubmed: 29713085
Nature. 2000 Mar 30;404(6777):506-10
pubmed: 10761920
Nat Med. 2006 Nov;12(11):1316-22
pubmed: 17057712
Cell Rep Med. 2021 Nov 16;2(11):100449
pubmed: 34841295
Cells. 2022 Jan 13;11(2):
pubmed: 35053386
Cytotherapy. 2019 Mar;21(3):327-340
pubmed: 30685216
Stem Cells Int. 2016;2016:8394960
pubmed: 27057178
Blood. 2012 Mar 22;119(12):2709-20
pubmed: 22160384
Am J Cancer Res. 2019 Oct 01;9(10):2064-2078
pubmed: 31720075
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4518-23
pubmed: 15758071
Sci Transl Med. 2018 Nov 28;10(469):
pubmed: 30487251
Nature. 2019 Dec;576(7786):293-300
pubmed: 31802004
Blood. 2006 Jul 15;108(2):487-92
pubmed: 16410443
Clin Cancer Res. 2011 Jul 1;17(13):4550-7
pubmed: 21498393
Stem Cell Res Ther. 2022 Mar 21;13(1):112
pubmed: 35313965
Sci Rep. 2017 Apr 7;7(1):737
pubmed: 28389661
Am J Cancer Res. 2018 Jun 01;8(6):1083-1089
pubmed: 30034945
Cancer Res. 2009 May 1;69(9):4010-7
pubmed: 19383914
Pediatr Transplant. 2005 Feb;9(1):9-16
pubmed: 15667605
Cell Stem Cell. 2014 Oct 2;15(4):471-487
pubmed: 25090446
J Hematol Oncol. 2018 Nov 27;11(1):132
pubmed: 30482221
BioDrugs. 2017 Dec;31(6):473-481
pubmed: 29143249
Stem Cells Transl Med. 2020 Sep;9(9):974-984
pubmed: 32416056
Nat Cancer. 2021 Sep;2(9):904-918
pubmed: 34746799
Stem Cells. 2018 Feb;36(2):134-145
pubmed: 29235195
Hum Reprod. 2009 Oct;24(10):2567-81
pubmed: 19556288
J Cancer. 2021 Jan 1;12(2):326-334
pubmed: 33391429
Cell. 1996 Nov 1;87(3):483-92
pubmed: 8898201
Annu Rev Immunol. 1999;17:283-95
pubmed: 10358760
Stem Cell Reports. 2017 Dec 12;9(6):1796-1812
pubmed: 29173894
Stem Cells Transl Med. 2015 Apr;4(4):381-8
pubmed: 25722426
Stem Cell Res. 2018 May;29:232-244
pubmed: 29751281
J Immunol. 2006 Nov 1;177(9):6548-59
pubmed: 17056587
Cancers (Basel). 2022 May 01;14(9):
pubmed: 35565395
Leukemia. 2018 Jul;32(7):1529-1541
pubmed: 29654266
Bone Marrow Transplant. 2003 Sep;32(5):505-10
pubmed: 12942097
Clin Cancer Res. 2009 Jan 1;15(1):169-80
pubmed: 19118044
Cell Stem Cell. 2019 Mar 7;24(3):376-389.e8
pubmed: 30661959
Nat Med. 2022 Feb;28(2):345-352
pubmed: 35027758
Mol Ther. 2017 Aug 2;25(8):1769-1781
pubmed: 28668320
Stem Cells Transl Med. 2012 May;1(5):353-8
pubmed: 23197814
Lancet Haematol. 2020 Feb;7(2):e157-e167
pubmed: 32004485
Front Oncol. 2020 Aug 05;10:1362
pubmed: 32850436
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20569-74
pubmed: 24259714
Blood. 2013 Aug 22;122(8):1341-9
pubmed: 23741009
Nat Biotechnol. 2008 Mar;26(3):313-5
pubmed: 18278034
Clin Cancer Res. 2017 May 1;23(9):2255-2266
pubmed: 27815355
Cancer J. 2015 Nov-Dec;21(6):450-64
pubmed: 26588676
Front Immunol. 2020 Feb 19;11:60
pubmed: 32140153
J Exp Med. 1998 Mar 2;187(5):813-8
pubmed: 9480992
Mol Ther. 2015 Aug;23(8):1380-1390
pubmed: 25939491
Immunity. 2018 Mar 20;48(3):453-473
pubmed: 29562195
Nat Biotechnol. 2013 Oct;31(10):928-33
pubmed: 23934177
Immunotargets Ther. 2019 Oct 29;8:43-52
pubmed: 31754614
Front Med (Lausanne). 2018 Apr 30;5:118
pubmed: 29761103
Nature. 2018 Aug;560(7718):325-330
pubmed: 30089904
Cell Stem Cell. 2020 Aug 6;27(2):224-237.e6
pubmed: 32531207
Methods Mol Biol. 2019;2048:107-119
pubmed: 31396935
Nat Med. 2012 May;18(5):807-815
pubmed: 22466705
Front Immunol. 2020 Nov 11;11:583716
pubmed: 33262761
Hum Immunol. 2021 Jul;82(7):457-465
pubmed: 32307125
Cell Stem Cell. 2010 Jul 2;7(1):11-4
pubmed: 20621043
Cell Stem Cell. 2018 Aug 02;23(2):181-192.e5
pubmed: 30082067
Stem Cells Transl Med. 2013 Mar;2(3):217-22
pubmed: 23408104
Nat Med. 2008 Dec;14(12):1390-5
pubmed: 18997777
Methods Mol Biol. 2020;2098:237-257
pubmed: 31792827
PLoS One. 2009 Dec 07;4(12):e8208
pubmed: 19997617
Immunology. 2007 Sep;122(1):1-14
pubmed: 17662044
Curr Mol Med. 2002 Jun;2(4):371-80
pubmed: 12108948
Cytotherapy. 2019 Nov;21(11):1095-1111
pubmed: 31711733
Nat Biomed Eng. 2018 Jun;2(6):377-391
pubmed: 31011197
Blood. 2020 Feb 6;135(6):399-410
pubmed: 31856277
Sci Signal. 2021 Aug 24;14(697):
pubmed: 34429382
Blood Rev. 2021 Jul;48:100792
pubmed: 33386151
Nat Biotechnol. 2017 Aug;35(8):765-772
pubmed: 28504668
Anesthesiol Clin. 2017 Sep;35(3):365-380
pubmed: 28784214
Pharm Res. 2021 Jun;38(6):931-945
pubmed: 34114161
Oncotarget. 2017 Jul 18;8(52):90521-90531
pubmed: 29163850
Eur J Pharmacol. 2022 Mar 15;919:174803
pubmed: 35131312
Oncotarget. 2017 Apr 29;8(37):62730-62741
pubmed: 28977984
Blood Adv. 2018 Feb 13;2(3):210-223
pubmed: 29386194
Cell Res. 2017 Jan;27(1):154-157
pubmed: 27910851
Blood Rev. 2019 Mar;34:45-55
pubmed: 30528964
Stem Cells. 2015 Nov;33(11):3174-80
pubmed: 26227158
Cell Mol Immunol. 2012 Jul;9(4):310-20
pubmed: 22705914
Nature. 2022 Mar;603(7903):934-941
pubmed: 35130560
Sci Transl Med. 2020 Nov 4;12(568):
pubmed: 33148626

Auteurs

Yan-Ruide Li (YR)

Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Zachary Spencer Dunn (ZS)

Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA 90089, USA.

Yanqi Yu (Y)

Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Miao Li (M)

Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Pin Wang (P)

Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA 90089, USA; Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA. Electronic address: pinwang@usc.edu.

Lili Yang (L)

Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: liliyang@ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH